Powered by
-
BIIB Stock Chart
Historical BIIB Prices
Biogen Idec Stock Analysis
Rating: Hold
Total Grade: C
Analysis Breakdown
| BIIB Stock Grade: | C |
| Fundamental Grade: | C |
| Quantitative Grade: | C |
| BIIB Earnings | |
| Earnings Growth: | B |
| Earnings Momentum: | F |
| Earnings Surprises: | C |
| Analyst Earnings Revisions: | D |
| BIIB Financial Information | |
| Sales Growth: | C |
| Operating Margin Growth: | B |
| Cash Flow: | B |
| Return on Equity: | A |
Biogen Idec Stock: Weekly View
| This Week: | C |
|---|---|
| Last Week: | C |
| Two Weeks Ago: | C |
BIIB Stock predictions, Articles, and Biogen Idec News
- From InvestorPlace
- From the Web
-
Biogen Inc Stock Got an Upgrade, but Should You Listen? - June 4, 2018
Analysts are buying into the recent resurgence of BIIB stock, but they may be ignoring serious fundamental headwinds. Here's a closer look at why investors should be cautious with Biogen Inc. Continue…
-
FDA Shame List: 40 Drug Makers That Try to Block Generic Drugs - May 18, 2018
The Food and Drug Administration (FDA) announced a list of drug makers that have tried to block generic drugs in its new shame list. Here they are. Continue…
-
The Good and the Bad News With Biogen Inc Earnings Results - April 30, 2018
Even before Biogen's quarterly report, BIIB stock sank after a series of disappointing clinical results. Investors have to weigh in the good and the bad developments ahead. Continue…
-
Here’s Why 275% in Biogen Inc Stock Looks Realistic - April 27, 2018
It’s not just as good as time as any to get long BIIB stock, it’s a better time than most using an October bull call spread. Continue…
-
Expect the Chaos to Continue With Today’s Jobs Report - April 6, 2018
U.S. stocks rallied for the third consecutive session on Thursday, with investors panic buying ahead of Friday's big non-farm payrolls report. Continue…
-
Buy the Bottom in Biogen Inc. Stock for a 100% Return - March 20, 2018
Biogen stock is ready to rebound from a dreadful February beating. Here's how to profit from a resurgent BIIB. Continue…
-
This week, Biogen (BIIB) a Sell - March 12, 2018
At $286.10, Biogen (BIIB) a Sell based on the most current comparative pricing of its shares and stock market ratings. Continue…
-
Biogen (BIIB) a Sell This Week - March 9, 2018
At $286.95, Biogen (BIIB) a Sell based on the most recent stock market rankings, and comparative pricing of its shares. Continue…
-
Hold for Biogen (BIIB) This Week - February 27, 2018
At $290.01, Biogen (BIIB) a Hold based on the latest relative pricing of its shares and stock market rankings. Continue…
-
Hold for Biogen (BIIB) This Week - February 16, 2018
Biogen (BIIB) remains a Hold this week based on the latest relative pricing of its shares and SEC filings. Continue…
